Seagen
SGEN
#552
Rank
A$64.83 B
Marketcap
A$343.65
Share price
-0.07%
Change (1 day)
63.68%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -A$1.2 Billion

According to Seagen 's latest financial reports the company's current earnings are A$2.30 Billion. In 2022 the company made an earning of -A$0.93 Billion, an increase over its 2021 earnings that were of -A$1.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -A$1.2 Billion29.54%
2022 -A$0.93 Billion-10.13%
2021 -A$1.03 Billion-214.28%
2020 A$0.89 B-370.63%
2019 -A$0.34 Billion-15.17%
2018 -A$0.4 Billion32.79%
2017 -A$0.3 Billion37.19%
2016 -A$0.22 Billion18%
2015 -A$0.19 Billion56.34%
2014 -A$0.12 Billion23.07%
2013 -A$94.44 Million
2011 -A$0.22 Billion111.72%
2010 -A$0.11 Billion-19.63%
2009 -A$0.13 Billion-7.55%
2008 -A$0.14 Billion64.95%
2007 -A$83.6 Million38.4%
2006 -A$60.41 Million25.36%
2005 -A$48.19 Million-14.86%
2004 -A$56.6 Million61.92%
2003 -A$34.95 Million-7.67%
2002 -A$37.86 Million6.76%
2001 -A$35.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.46 B-981.38%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$19.25 B-1,720.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$0.66 B-156.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$17.02 B-1,533.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.74 B-1,004.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$92.97 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-A$94.32 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.49 Billion-58.79%๐Ÿ‡บ๐Ÿ‡ธ USA